Presidio talks up NS5A program: http://finance.yahoo.com/news/Presidio-Pharmaceuticals-Inc-bw-1622780186.html?x=0&.v=1 I’m skeptical of PPI-461 for the reason set forth in the header of #msg-52296077. PPI-668 is a newly disclosed compound.